| REGISTERED NUMBER: |
| FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024 |
| FOR |
| PROMEDICA PLUS UK LIMITED |
| REGISTERED NUMBER: |
| FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024 |
| FOR |
| PROMEDICA PLUS UK LIMITED |
| PROMEDICA PLUS UK LIMITED (REGISTERED NUMBER: 09355671) |
| CONTENTS OF THE FINANCIAL STATEMENTS |
| For The Year Ended 31 December 2024 |
| Page |
| Company Information | 1 |
| Balance Sheet | 2 |
| Notes to the Financial Statements | 3 |
| PROMEDICA PLUS UK LIMITED |
| COMPANY INFORMATION |
| For The Year Ended 31 December 2024 |
| DIRECTORS: |
| REGISTERED OFFICE: |
| REGISTERED NUMBER: |
| PROMEDICA PLUS UK LIMITED (REGISTERED NUMBER: 09355671) |
| BALANCE SHEET |
| 31 December 2024 |
| 2024 | 2023 |
| Notes | £ | £ |
| CURRENT ASSETS |
| Debtors | 5 |
| Cash at bank |
| CREDITORS |
| Amounts falling due within one year | 6 |
| NET CURRENT ASSETS |
| TOTAL ASSETS LESS CURRENT LIABILITIES |
| CAPITAL AND RESERVES |
| Called up share capital |
| Retained earnings |
| SHAREHOLDERS' FUNDS |
| The financial statements were approved by the Board of Directors and authorised for issue on |
| PROMEDICA PLUS UK LIMITED (REGISTERED NUMBER: 09355671) |
| NOTES TO THE FINANCIAL STATEMENTS |
| For The Year Ended 31 December 2024 |
| 1. | STATUTORY INFORMATION |
| Promedica Plus UK Limited is a |
| 2. | ACCOUNTING POLICIES |
| Basis of preparing the financial statements |
| Related party exemption |
| The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group. |
| Turnover |
| Turnover is made up of sales of franchise fees and intragroup recharges, excluding value added tax. |
| Sales of franchise fees are comprised of an initial setup fee, which is recognised on the date the agreement is signed, and ongoing monthly management and marketing fees which are included on a monthly basis with adjustments made for accrued or deferred income. |
| Intragroup recharges |
| The company incurs costs throughout the year which relate to the UK based operation and these are recharged monthly to the other UK based trading companies and shown within 'Turnover'. |
| The recharges are calculated based on the turnover of each individual company as a percentage of the total turnover of all UK trading companies, in line with a formula which is defined in the intercompany agreement. At the end of the year, Management reserve the right to make an adjustment to the recharge to ensure that the costs in each of the individual companies are in line with the turnover of that company. |
| Intangible assets |
| Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses. |
| Tangible fixed assets |
| Tangible fixed assets are stated at cost or valuation less accumulated depreciation. Cost includes costs directly attributable to making the asset capable of operating as intended by management. |
| Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful |
| life. |
| Fixtures and fittings | - | 25% on cost |
| Financial instruments |
| The company enters into basic financial instruments, which result in the recognition of financial assets and liabilities. Financial instruments are recognised at amortised cost. At the end of each reporting period financial instruments are assessed for evidence of impairment, and changes are recognised in profit or loss. |
| PROMEDICA PLUS UK LIMITED (REGISTERED NUMBER: 09355671) |
| NOTES TO THE FINANCIAL STATEMENTS - continued |
| For The Year Ended 31 December 2024 |
| 2. | ACCOUNTING POLICIES - continued |
| Taxation |
| Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. |
| Current tax represents the amount of tax payable or receivable in respect of the taxable profit (or loss) for the current or past reporting periods. |
| Deferred tax represents the future tax consequences of material transactions and events recognised in the financial statements of current and previous periods. |
| Current and deferred tax assets and liabilities are not discounted and are recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date. |
| 3. | EMPLOYEES AND DIRECTORS |
| The average number of employees during the year was |
| 4. | INTANGIBLE FIXED ASSETS |
| Other |
| intangible |
| assets |
| £ |
| COST |
| At 1 January 2024 |
| and 31 December 2024 |
| AMORTISATION |
| At 1 January 2024 |
| and 31 December 2024 |
| NET BOOK VALUE |
| At 31 December 2024 |
| At 31 December 2023 |
| 5. | DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
| 2024 | 2023 |
| £ | £ |
| Trade debtors |
| Balances due from group undertakings | 166,143 | 141,791 |
| Prepayments and accrued income |
| 6. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
| 2024 | 2023 |
| £ | £ |
| Trade creditors |
| Balances due to group undertakings |
| Social security and other taxes |
| Accruals and deferred income |
| PROMEDICA PLUS UK LIMITED (REGISTERED NUMBER: 09355671) |
| NOTES TO THE FINANCIAL STATEMENTS - continued |
| For The Year Ended 31 December 2024 |
| 7. | DISCLOSURE UNDER SECTION 444(5B) OF THE COMPANIES ACT 2006 |
| The Report of the Auditors was unqualified. |
| for and on behalf of |
| 8. | RELATED PARTY DISCLOSURES |
| At the balance sheet date, the amounts due from and to group companies were as follows: |
| Due from Promedica24 (Lancashire) Ltd | - | £166,143 | (2023 - £141,791) |
| Due to Promedica24 UK Limited | - | £nil | (2023 - £2,396) |
| These amounts are included in 'Balances due from group undertakings' and 'Balances due to group undertakings' respectively. |
| 9. | ULTIMATE PARENT UNDERTAKING |
| The ultimate parent undertaking is PineBridge New Europe Partners II-A, L.P., a company registered in the state of Cayman Islands. The parent's business and mailing address is 399 Park Avenue, 4th Floor, New York, NY, 10022. |